GW Researchers Coordinate Study of Fetal Surgery to Reduce Complications of Spina Bifida

February 7, 2011

WASHINGTON – Researchers at The George Washington University Medical Center played a key role in a National Institutes of Health (NIH) study of a surgical procedure to repair a common birth defect of the spine, which if undertaken while a baby is still in the uterus, greatly reduces the need to divert, or shunt, fluid away from the brain. The study was published online in the New England Journal of Medicine on February 9, 2011.

The multi-center clinical trial, called the Management of Myelomeningocele Study (MOMS), was coordinated by researchers at The George Washington University Biostatistics Center. Their work included study design, setting up the study website and randomization system, screening and evaluating patients, creating case report forms and manuals of procedures, quality control and management of the data,  statistical analysis of the  data, and organization of outcome reviews and follow-up teams. 

"GW’s role was to make sure the study was conducted to the highest standards possible, the data were as accurate as possible, and the analysis was conducted in the most appropriate manner,” said Elizabeth Thom, Ph.D., Principal Investigator for the Data and Study Coordinating Center of MOMS and Associate Director of The George Washington University Biostatistics Center. “The goal was to ensure that the study results can inform future clinical practice.”

The study was funded by NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The Children’s Hospital of Philadelphia (CHOP), the University of California San Francisco (UCSF) and Vanderbilt University Medical Center in Nashville served as the clinical centers for the study.

Read the study, published online in the New England Journal of Medicine

Latest News

September 21, 2023
As part of its mission to provide therapeutic skincare for all, CeraVe is reinforcing its commitment to making dermatology more accessible for both patients and students hoping to enter the field through a new partnership with George Washington University.
September 20, 2023
Michael Bukrinsky, MD, PhD, professor of microbiology, immunology, and tropical medicine, received a 2023 Fulbright Specialist Program grant in support of an international educational exchange with University of Ostrava in the Czechia.
September 15, 2023
Anne Chiaramello, PhD, founding director the Mito-EpiGen Program at the George Washington University (GW) School of Medicine and Health Sciences (SMHS) received FDA approval for the first basket clinical trial in the US for two ultra-rare inherited mitochondrial diseases, MELAS and LHON-Plus.